Joachim Diessner
Overview
Explore the profile of Joachim Diessner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
333
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Scherer-Quenzer A, Findeis J, Herbert S, Yokendren N, Reinhold A, Schlaiss T, et al.
BMC Womens Health
. 2024 Aug;
24(1):461.
PMID: 39169335
Background: Cervical cancer often originates from cervical cell dysplasia. Previous studies mainly focused on surgical margins and high-risk human papillomavirus persistence as factors predicting recurrence. New research highlights the significance...
2.
Scherer-Quenzer A, Herbert S, Schlaiss T, Wockel A, Diessner J, Grunz J, et al.
Arch Gynecol Obstet
. 2024 Aug;
310(4):2173-2181.
PMID: 39090472
Purpose: This study aims to investigate the psychological distress experienced by patients with an initial diagnosis of abnormal Pap smears or dysplastic changes of the cervix uteri. It investigated whether...
3.
Iwanowitsch A, Diessner J, Bergmann B, Rudel T
Vaccines (Basel)
. 2024 Jun;
12(6).
PMID: 38932416
Serovar Typhi Ty21a (Ty21a) is the only licensed oral vaccine against typhoid fever. Due to its excellent safety profile, it has been used as a promising vector strain for the...
4.
Wolkersdorfer A, Jugovic I, Scheller L, Gutmann M, Hahn L, Diessner J, et al.
ACS Biomater Sci Eng
. 2023 Jun;
10(1):149-155.
PMID: 37296497
Vascular endothelial growth factor A-165 (VEGF-A) positively modulates neointimal hyperplasia, lumen stenosis, and neovascularization. One challenge for the use of VEGF-A for potential therapy is its short serum half-life. Therefore,...
5.
Schlaiss T, Singer S, Herbert S, Diessner J, Bartmann C, Kiesel M, et al.
Geburtshilfe Frauenheilkd
. 2023 Jun;
83(6):702-707.
PMID: 37288248
To evaluate the proportion of breast cancer (BC) patients with distress or psychological comorbidity as well as offer and use of psychological support in subgroups of BC patients with different...
6.
Herbert S, Flock F, Felberbaum R, Janni W, Lob S, Kiesel M, et al.
J Breast Cancer
. 2023 Jun;
26(3):243-253.
PMID: 37272248
Purpose: Due to improved therapy, early diagnosis, and growing incidence rates, the number of long-term breast cancer survivors is increasing. Survivors can still be affected by aftercare, resulting in reduced...
7.
Hung S, Kasperkowitz A, Kurz F, Dreher L, Diessner J, Ibrahim E, et al.
Front Immunol
. 2023 Mar;
14:1127709.
PMID: 36969151
Humanized hemato-lymphoid system mice, or humanized mice, emerged in recent years as a promising model to study the course of infection of human-adapted or human-specific pathogens. Though infects and colonizes...
8.
Lob S, Linsmeier E, Herbert S, Schlaiss T, Kiesel M, Wischhusen J, et al.
J Cancer Res Clin Oncol
. 2022 Nov;
149(8):5417-5428.
PMID: 36451043
Purpose: Therapeutic options for breast cancer (BC) treatment are constantly evolving. The Human Epidermal Growth Factor 2 (HER2)-low BC entity is a new subgroup, representing about 55% of all BC...
9.
Hubner T, Wolfgang T, Theis A, Steber M, Wiedenmann L, Wockel A, et al.
Reprod Health
. 2022 Sep;
19(1):189.
PMID: 36064560
Background: The onset of mental illness such as depression and anxiety disorders in pregnancy and postpartum period is common. The coronavirus induced disease 2019 (COVID-19) pandemic and the resulting public...
10.
Diessner J, Anders L, Herbert S, Kiesel M, Bley T, Schlaiss T, et al.
J Cancer Res Clin Oncol
. 2022 Aug;
149(7):3457-3467.
PMID: 35948829
Purpose: The reliable detection of tumor-infiltrated axillary lymph nodes for breast cancer [BC] patients plays a decisive role in further therapy. We aimed to find out whether cross-sectional imaging techniques...